Adenovirus infection in pediatric small bowel transplantation recipients

Rebecca J. Pinchoff, Stuart S. Kaufman, Margret S. Magid, Dean D. Erdman, Gabriel E. Gondolesi, Meryl H. Mendelson, Kliti Tane, Stephen G. Jenkins, Thomas M. Fishbein, Betsy Herold

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Background. The purpose of this study was to determine the prevalence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine risk factors for progression to histologic disease, and examine the impact of adenovirus on outcome. Methods. Beginning in July 2000, all SBT recipients had viral cultures for adenovirus, cytomegalovirus (CMV), and herpes simplex virus (HSV) obtained routinely during graft biopsies. The medical records were retrospectively reviewed for frequency and site of viral culture, types and doses of immunosuppressive drugs, episodes of rejection, histology of allograft biopsies, and other infections. Adenoviral isolates were typed by polymerase chain reaction and type-specific neutralization assays. Results. All 14 SBT recipients who met enrollment criteria had evidence of adenoviral infection (intestinal graft, 13; liver graft, 1). Eight of 14 developed histologic disease with identifiable adenoviral intranuclear inclusions. In contrast, CMV enteritis was identified in only one patient, who subsequently also developed adenoviral disease. No other viruses were detected. Adenoviral cultures were first positive within 30 days of transplant in nine. Patients with histologic disease were more likely than those without to have received intensive corticosteroid therapy (P<0.007), had virus isolated from more than one site (P=0.03), and had persistent positive cultures (P<0.01). Conclusions. Adenovirus was commonly isolated from children undergoing intestinal transplantation. Progression to disease may be associated with more intensive immunosuppressive therapy and inability to clear virus.

Original languageEnglish (US)
Pages (from-to)183-189
Number of pages7
JournalTransplantation
Volume76
Issue number1
StatePublished - Jul 15 2003
Externally publishedYes

Fingerprint

Adenoviridae Infections
Transplantation
Adenoviridae
Pediatrics
Transplants
Immunosuppressive Agents
Viruses
Cytomegalovirus
Infection
Biopsy
Intranuclear Inclusion Bodies
Enteritis
Simplexvirus
Medical Records
Allografts
Disease Progression
Histology
Adrenal Cortex Hormones
Polymerase Chain Reaction
Liver

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Pinchoff, R. J., Kaufman, S. S., Magid, M. S., Erdman, D. D., Gondolesi, G. E., Mendelson, M. H., ... Herold, B. (2003). Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation, 76(1), 183-189.

Adenovirus infection in pediatric small bowel transplantation recipients. / Pinchoff, Rebecca J.; Kaufman, Stuart S.; Magid, Margret S.; Erdman, Dean D.; Gondolesi, Gabriel E.; Mendelson, Meryl H.; Tane, Kliti; Jenkins, Stephen G.; Fishbein, Thomas M.; Herold, Betsy.

In: Transplantation, Vol. 76, No. 1, 15.07.2003, p. 183-189.

Research output: Contribution to journalArticle

Pinchoff, RJ, Kaufman, SS, Magid, MS, Erdman, DD, Gondolesi, GE, Mendelson, MH, Tane, K, Jenkins, SG, Fishbein, TM & Herold, B 2003, 'Adenovirus infection in pediatric small bowel transplantation recipients', Transplantation, vol. 76, no. 1, pp. 183-189.
Pinchoff RJ, Kaufman SS, Magid MS, Erdman DD, Gondolesi GE, Mendelson MH et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation. 2003 Jul 15;76(1):183-189.
Pinchoff, Rebecca J. ; Kaufman, Stuart S. ; Magid, Margret S. ; Erdman, Dean D. ; Gondolesi, Gabriel E. ; Mendelson, Meryl H. ; Tane, Kliti ; Jenkins, Stephen G. ; Fishbein, Thomas M. ; Herold, Betsy. / Adenovirus infection in pediatric small bowel transplantation recipients. In: Transplantation. 2003 ; Vol. 76, No. 1. pp. 183-189.
@article{a8f4aa211fc4477ab9be21307b098a57,
title = "Adenovirus infection in pediatric small bowel transplantation recipients",
abstract = "Background. The purpose of this study was to determine the prevalence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine risk factors for progression to histologic disease, and examine the impact of adenovirus on outcome. Methods. Beginning in July 2000, all SBT recipients had viral cultures for adenovirus, cytomegalovirus (CMV), and herpes simplex virus (HSV) obtained routinely during graft biopsies. The medical records were retrospectively reviewed for frequency and site of viral culture, types and doses of immunosuppressive drugs, episodes of rejection, histology of allograft biopsies, and other infections. Adenoviral isolates were typed by polymerase chain reaction and type-specific neutralization assays. Results. All 14 SBT recipients who met enrollment criteria had evidence of adenoviral infection (intestinal graft, 13; liver graft, 1). Eight of 14 developed histologic disease with identifiable adenoviral intranuclear inclusions. In contrast, CMV enteritis was identified in only one patient, who subsequently also developed adenoviral disease. No other viruses were detected. Adenoviral cultures were first positive within 30 days of transplant in nine. Patients with histologic disease were more likely than those without to have received intensive corticosteroid therapy (P<0.007), had virus isolated from more than one site (P=0.03), and had persistent positive cultures (P<0.01). Conclusions. Adenovirus was commonly isolated from children undergoing intestinal transplantation. Progression to disease may be associated with more intensive immunosuppressive therapy and inability to clear virus.",
author = "Pinchoff, {Rebecca J.} and Kaufman, {Stuart S.} and Magid, {Margret S.} and Erdman, {Dean D.} and Gondolesi, {Gabriel E.} and Mendelson, {Meryl H.} and Kliti Tane and Jenkins, {Stephen G.} and Fishbein, {Thomas M.} and Betsy Herold",
year = "2003",
month = "7",
day = "15",
language = "English (US)",
volume = "76",
pages = "183--189",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Adenovirus infection in pediatric small bowel transplantation recipients

AU - Pinchoff, Rebecca J.

AU - Kaufman, Stuart S.

AU - Magid, Margret S.

AU - Erdman, Dean D.

AU - Gondolesi, Gabriel E.

AU - Mendelson, Meryl H.

AU - Tane, Kliti

AU - Jenkins, Stephen G.

AU - Fishbein, Thomas M.

AU - Herold, Betsy

PY - 2003/7/15

Y1 - 2003/7/15

N2 - Background. The purpose of this study was to determine the prevalence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine risk factors for progression to histologic disease, and examine the impact of adenovirus on outcome. Methods. Beginning in July 2000, all SBT recipients had viral cultures for adenovirus, cytomegalovirus (CMV), and herpes simplex virus (HSV) obtained routinely during graft biopsies. The medical records were retrospectively reviewed for frequency and site of viral culture, types and doses of immunosuppressive drugs, episodes of rejection, histology of allograft biopsies, and other infections. Adenoviral isolates were typed by polymerase chain reaction and type-specific neutralization assays. Results. All 14 SBT recipients who met enrollment criteria had evidence of adenoviral infection (intestinal graft, 13; liver graft, 1). Eight of 14 developed histologic disease with identifiable adenoviral intranuclear inclusions. In contrast, CMV enteritis was identified in only one patient, who subsequently also developed adenoviral disease. No other viruses were detected. Adenoviral cultures were first positive within 30 days of transplant in nine. Patients with histologic disease were more likely than those without to have received intensive corticosteroid therapy (P<0.007), had virus isolated from more than one site (P=0.03), and had persistent positive cultures (P<0.01). Conclusions. Adenovirus was commonly isolated from children undergoing intestinal transplantation. Progression to disease may be associated with more intensive immunosuppressive therapy and inability to clear virus.

AB - Background. The purpose of this study was to determine the prevalence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine risk factors for progression to histologic disease, and examine the impact of adenovirus on outcome. Methods. Beginning in July 2000, all SBT recipients had viral cultures for adenovirus, cytomegalovirus (CMV), and herpes simplex virus (HSV) obtained routinely during graft biopsies. The medical records were retrospectively reviewed for frequency and site of viral culture, types and doses of immunosuppressive drugs, episodes of rejection, histology of allograft biopsies, and other infections. Adenoviral isolates were typed by polymerase chain reaction and type-specific neutralization assays. Results. All 14 SBT recipients who met enrollment criteria had evidence of adenoviral infection (intestinal graft, 13; liver graft, 1). Eight of 14 developed histologic disease with identifiable adenoviral intranuclear inclusions. In contrast, CMV enteritis was identified in only one patient, who subsequently also developed adenoviral disease. No other viruses were detected. Adenoviral cultures were first positive within 30 days of transplant in nine. Patients with histologic disease were more likely than those without to have received intensive corticosteroid therapy (P<0.007), had virus isolated from more than one site (P=0.03), and had persistent positive cultures (P<0.01). Conclusions. Adenovirus was commonly isolated from children undergoing intestinal transplantation. Progression to disease may be associated with more intensive immunosuppressive therapy and inability to clear virus.

UR - http://www.scopus.com/inward/record.url?scp=0038299439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038299439&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 183

EP - 189

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -